Prestige Brand Holdings Inc Market Cap ($2.32 Billion)
Market Cap & Net Worth: Prestige Brand Holdings Inc (PBH)
Prestige Brand Holdings Inc market cap. Prestige Brand Holdings Inc (NYSE:PBH) has a market capitalization of $2.32 Billion ($2.32 Billion) as of November 1, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #5444 globally and #1828 in its home market, demonstrating a -0.81% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prestige Brand Holdings Inc's stock price $49.06 by its total outstanding shares 47372166 (47.37 Million). Also see cash flow conversion of Prestige Brand Holdings Inc for how efficiently the company converts equity into cash flow.
Prestige Brand Holdings Inc Market Cap History (2015–2026)
Prestige Brand Holdings Inc market cap history from 2015 to 2026. Data shows growth from $2.41 Billion to $2.32 Billion (0.14% CAGR). Check Prestige Brand Holdings Inc (PBH) share price today for real-time trading data and today's change.
Index Memberships
Prestige Brand Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Pharmaceutical
DRG
|
$3.45 Trillion | 0.07% | #19 of 24 |
|
S&P Small-Cap 600 Index
SML
|
$1.56 Trillion | 0.35% | #273 of 602 |
Weight: Prestige Brand Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Prestige Brand Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prestige Brand Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Prestige Brand Holdings Inc (PBH) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.13x
Prestige Brand Holdings Inc's market cap is 2.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
12.21x
Prestige Brand Holdings Inc's market cap is 12.21 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.08 Billion | $882.06 Million | $69.39 Million | 2.36x | 29.94x |
| 2018 | $1.46 Billion | $1.04 Billion | $339.57 Million | 1.40x | 4.31x |
| 2019 | $1.92 Billion | $975.78 Million | -$35.80 Million | 1.97x | N/A |
| 2020 | $1.65 Billion | $963.01 Million | $142.28 Million | 1.72x | 11.61x |
| 2021 | $2.87 Billion | $943.37 Million | $164.68 Million | 3.05x | 17.45x |
| 2022 | $2.97 Billion | $1.09 Billion | $205.38 Million | 2.73x | 14.44x |
| 2023 | $2.90 Billion | $1.13 Billion | -$82.31 Million | 2.57x | N/A |
| 2024 | $3.70 Billion | $1.13 Billion | $209.34 Million | 3.29x | 17.67x |
| 2025 | $2.92 Billion | $1.14 Billion | $214.60 Million | 2.57x | 13.62x |
| 2026 | $2.32 Billion | $1.09 Billion | $190.30 Million | 2.13x | 12.21x |
Competitor Companies of PBH by Market Capitalization
Companies near Prestige Brand Holdings Inc in the global market cap rankings as of November 1, 2026. Also see PBH asset base for a full breakdown of the balance sheet.
Key companies related to Prestige Brand Holdings Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Prestige Brand Holdings Inc (2015–2026)
Market capitalization of Prestige Brand Holdings Inc from 2015 to today. Between 2015 and today, Prestige Brand Holdings Inc's market cap moved from $2.41 Billion to $ 2.32 Billion, with a yearly change of 0.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.32 Billion | -20.47% |
| 2025 | $2.92 Billion | -21.00% |
| 2024 | $3.70 Billion | +27.56% |
| 2023 | $2.90 Billion | -2.20% |
| 2022 | $2.97 Billion | +3.22% |
| 2021 | $2.87 Billion | +73.93% |
| 2020 | $1.65 Billion | -13.90% |
| 2019 | $1.92 Billion | +31.15% |
| 2018 | $1.46 Billion | -29.59% |
| 2017 | $2.08 Billion | -14.76% |
| 2016 | $2.44 Billion | +1.20% |
| 2015 | $2.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Prestige Brand Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.32 Billion USD |
| MoneyControl | $2.32 Billion USD |
| MarketWatch | $2.32 Billion USD |
| marketcap.company | $2.32 Billion USD |
| Reuters | $2.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Prestige Brand Holdings Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various… Read more